Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 811 results for "daiichi sankyo company"

Daiichi Sankyo and Eli Lilly and Company: Heart patients in En...

GERRARDS CROSS, England--(BUSINESS WIRE)--Jul. 23, 2014-- Revised guidance from the National Institute for Health and Care Excellence (NICE), recommends once-daily, oral antiplatelet prasugrel (Efient), in combination with aspirin, as a ... BusinessWeek, 1 week ago
Court Report - July 2014 #2 JD Supra, 3 weeks ago
[x]  

29 images for daiichi sankyo company

4 Traders, 3 weeks ago
4 Traders, 1 month ago
companiesandmarkets.com, 1 month ago
Broadway World, 4 months ago
4 Traders, 6 months ago
TeleTrader.com, 2 months ago
Rediff.com, 3 months ago
Rediff.com, 3 months ago
The Freepress Journal, 3 months ago
Prolific North, 2 months ago
4 Traders

Daiichi Sankyo Concludes Basic Agreement for Transfer of Daiichi Sankyo Propharma Akita Plant and Decides Reorganization of Japanese Supply Chain Subsidiaries

Company name: DAIICHI SANKYO COMPANY, LIMITED Representative: Joji Nakayama, Representative Director, President and CEO (Code no.: 4568, First Section, Tokyo Stock Exchange) Please address inquiries to Noriaki Ishida, Corporate Officer, Vice ...
 Noodls1 day ago DAIICHI SANKYO : Correction to the release titled "Ranbaxy Q1 FY 2015(Apr'14-Jun'14) Sales Rs.23.7 Bn"  4 Traders2 days ago Ranbaxy Laboratories : DAIICHI-SANKYO -Ranbaxy Q1 FY 2015 (Apr'14-Jun'14) Sales Rs.23.7 Bn Growth registered in Base business profitability  4 Traders2 days ago DAIICHI SANKYO - Ranbaxy Q1 FY 2015 (Apr'14-Jun'14) Sales Rs.23.7 Bn Growth registered in Base business profitability  TMC Net1 day ago
[x]  

American Regent's Injectafer® (Ferric Carboxymaltose Injection) Now the Fastest Growing IV Iron in United States

American Regent, Inc., a subsidiary of Luitpold Pharmaceuticals, Inc. (a Daiichi Sankyo Group Company), announced today the double-digit sales growth of Injectafer ® (ferric carboxymaltose injection) in 2014, making it the ...
 Town Hall2 weeks ago American Regent Reports Sales Growth of Injectafer  Pharmaceutical & Medical Packaging News1 week ago American Regent's Injectafer (Ferric Carboxymaltose Injection) Now the Fastest Growing IV Iron in United States  Pharmacy Choice2 weeks ago American Regent's Injectafer(r) (Ferric Carboxymaltose Injection) N...  Finwin2 weeks ago
[x]  

Portola Pharmaceuticals inks latest blood thinner antidote deal

Daiichi Sankyo for late-stage clinical testing of a drug for people taking anticoagulants -- the company's third such deal with new-generation blood-thinning drugs in the past two years.
 Big News Network3 weeks ago
Livemint.com

Sun Pharma-Ranbaxy deal in CCI crosshairs

Sun Pharma agreed to buy Ranbaxy for $3.2 billion in stock from its Japanese parent Daiichi Sankyo Co. Ltd. It also agreed to take on $800 million of Ranbaxy's debt. Photo: Hemant Mishra/Mint New Delhi: Sun Pharmaceutical Industries Ltd 's ...
 Livemint.com3 days ago Sun Pharma-Ranbaxy merger gets BSE, NSE clearance  Livemint.com1 week ago Sun Pharma-Ranbaxy deal gets BSE, NSE clearance  Deccan Chronicle1 week ago Ranbaxy is now Daiichi's  Pune Mirror2 weeks ago
[x]  

DAIICHI SANKYO -Announcement on obtaining in Japan the marketing and manufacturing license for the 4-valent combination vaccine for the prevention of Pertussis, Diphtheria, Tetanus and Poliomyelitis (Polio) 'Squarekids subcutaneous injection syringe'

[July 08, 2014] (ENP Newswire Via Acquire Media NewsEdge) ENP Newswire - 08 July 2014 Release date- 04072014 - Tokyo, Japan - Daiichi Sankyo Co., Ltd. (hereinafter Daiichi Sankyo) and Sanofi K.K. announce that Kitasato Daiichi ...
 TMC Net3 weeks ago DAIICHI SANKYO : Announcement on obtaining in Japan the marketing and manufacturing license for the 4-valent combination vaccine for the prevention of Pertussis, Diphtheria, Tetanus and Poliomyelitis (Polio) 'Squarekids subcutaneous injection syringe'  4 Traders3 weeks ago Announcement on obtaining in Japan the marketing and manufacturing license for the 4-valent combination vaccine for the prevention of Pertussis, Diphtheria, Tetanus and Poliomyelitis (Polio) Squarekids® subcutaneous injection syringe  Noodls4 weeks ago
[x]  

DAIICHI SANKYO -Marketing and Manufacturing Approval in Japan Received for CANAGLU Tablets 100mg

[July 08, 2014] (ENP Newswire Via Acquire Media NewsEdge) ENP Newswire - 08 July 2014 Release date- 04072014 - Osaka and Tokyo, Japan, -Mitsubishi Tanabe Pharma Corporation (hereafter, Mitsubishi Tanabe Pharma; Head Office: ...
 TMC Net3 weeks ago Japan marketing approval for Canaglu; Vaccine license for Daiichi Sankyo  Pharma Letter4 weeks ago Marketing and Manufacturing Approval in Japan Received for CANAGLU® Tablets 100mg  Noodls4 weeks ago DAIICHI SANKYO : Marketing and Manufacturing Approval in Japan Received for CANAGLU® Tablets 100mg  4 Traders4 weeks ago
Scottrade

Portola, Daiichi Sankyo collaborate for Phase III studies of factor Xa inhibitor antidote

Portola Pharmaceuticals has entered into clinical collaboration agreement with Daiichi Sankyo to carry out Phase III studies of factor Xa inhibitor antidote, andexanet alfa and edoxaban. Andexanet alfa is Portola's investigational Factor Xa ...
 Pharmaceutical Business Review3 weeks ago Portola Pharmaceuticals to Announce Second Quarter 2014 Financial Results and Host Conference Call on …  Yahoo! Finance2 days ago Portola Pharmaceuticals Enters Into Clinical Collaboration Agreement With Daiichi Sankyo for Phase 3 Studies of Factor Xa Inhibitor Antidote, Andexanet Alfa, and Edoxaban  MoneyShow.com3 weeks ago Portola Pharmaceuticals, Inc. Enters Into Clinical Collaboration Agreement With Daiichi Sankyo, Inc. For Phase 3 Studies Of Factor Xa Inhibitor Antidote, Andexanet Alfa, And Edoxaban  BioSpace3 weeks ago
[x]  

Chinese Pharmaceutical Market: Forecasts and Outlooks 2014-2024

/PRNewswire/ -- Medical revenues in China - your guide to trends, companies and potentials What's the outlook for the Chinese pharma market ? Can it sustain high growth? Visiongain 's updated report gives you forecasted revenues there to 2024.
 Yahoo! Finance3 days ago
Scottrade

Pipeline Analysis and Sales Projections of the Top 25 Pharmaceutical Companies 2013-2023

Research and Markets (http://www.researchandmarkets.com/research/7pjm9m/top_25) has announced the addition of the "Top 25 Pharmaceutical Company Pipeline Analysis and Sales Projections to 2023" report to their offering. Top 25 Pharmaceutical Company ...
 Individual.com1 week ago Research and Markets: Pipeline Analysis and Sales Projections of the Top 25 Pharmaceutical Companies 2013-2023  TMC Net1 week ago RESEARCH AND MARKETS : Pipeline Analysis and Sales Projections of the Top 25 Pharmaceutical Companies 2013-2023  4 Traders1 week ago Research and Markets: Global Rheumatoid Arthritis Drugs Market 2014-2018  Business Wire4 days ago
[x]  
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less